MIRCERA 250 MCG/0.3 ML

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 250 MCG / 0.3 ML

MAH:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC_code:

B03XA03

pharmaceutical_form:

SOLUTION FOR INJECTION

administration_route:

I.V, S.C

manufactured_by:

ROCHE DIAGNOSTICS GmbH ,GERMANY

therapeutic_group:

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

therapeutic_indication:

Treatment of anemia associated with chronic kidney disease (CKD).

authorization_date:

2013-04-01